Celebrating Talkiatry's Outstanding Achievement in Virtual Care
Talkiatry has recently achieved a significant milestone by being recognized as the "Best Virtual Care Platform" in the prestigious MedTech Breakthrough Awards. This independent awards program highlights companies making headway in digital health and medical technology, showcasing innovations that significantly enhance patient care.
The Essence of Talkiatry's Care Model
At the core of Talkiatry's approach is a commitment to providing high-quality and accessible psychiatric care. With partnerships across more than 60 health plans, including major insurers like Aetna and UnitedHealthcare, Talkiatry supports a vast network of patients seeking mental health services. Its team comprises over 500 licensed psychiatrists operating across 47 states, indicating a robust framework ready to serve those in need.
Transforming Mental Health Access
Talkiatry's innovative virtual-first model connects patients to psychiatrists within minutes, allowing them to schedule appointments swiftly. This is especially beneficial in today's fast-paced world, where timely access to mental health services can be transformative. The platform notably accommodates a variety of mental health conditions such as anxiety, depression, ADHD, PTSD, and bipolar disorder, among others, ensuring that individuals receive the care they require.
Impact on Patient Outcomes
Research surrounding Talkiatry's care model demonstrates its effectiveness. In one compelling study, 67% of Talkiatry's patients reported no longer experiencing clinically significant anxiety symptoms after 15 weeks of treatment, while 62% experienced improvements in their depression symptoms. These metrics underline the organization’s commitment to outcomes-driven care designed to foster healing in a trusting environment.
Adapting Treatment to Meet Needs
The lengthy initial evaluations for adults, lasting 60 minutes, alongside follow-up sessions extending 30 minutes, are tailored to achieve thorough assessments and personalized care plans. Special provisions are made for youth and geriatric patients to ensure none of their unique needs are overlooked, demonstrating Talkiatry's dedication to comprehensive mental health support.
Leadership's Vision
Robert Krayn, CEO of Talkiatry, expressed pride in the recognition from MedTech Breakthrough, emphasizing the strength of their clinical team. He elaborated on their commitment to making high-quality mental health care accessible to the millions who require support. This forward-thinking ethos positions Talkiatry as a leader in behavioral health innovation.
About Talkiatry
Founded to address the challenges in accessing quality mental healthcare, Talkiatry is transforming psychiatric treatment across the nation. Co-founded by a dedicated patient and a triple-board-certified psychiatrist, the practice emerged from a deep understanding of the barriers patients face. With a substantial percentage of adults experiencing untreated mental illness annually and numerous clinicians remaining out of network due to systemic challenges, Talkiatry employs cutting-edge technology infused with a human-centered philosophy, enabling a more effective approach to mental health care.
Frequently Asked Questions
What awards has Talkiatry recently won?
Talkiatry was named the "Best Virtual Care Platform" in the 2025 MedTech Breakthrough Awards.
How does Talkiatry's virtual-first model work?
Patients can quickly match with an in-network psychiatrist and schedule appointments within days, enhancing accessibility and timely care.
What conditions does Talkiatry treat?
Talkiatry provides care for various mental health conditions, including anxiety, depression, ADHD, PTSD, and bipolar disorder.
What are the average session lengths at Talkiatry?
Adult evaluations are 60 minutes long, with 30-minute follow-up appointments, while youth and geriatric sessions may be extended.
What is Talkiatry's approach to patient outcomes?
Talkiatry focuses on evidence-based care with proven improvements in mental health symptoms for many of its patients.